NuvOx Pharma, a clinical stage biotechnology company, has received a Phase I SBIR grant for $150,000 from the National Institutes of Health, specifically the National Institute of Neurological Diseases and Stroke. Evan Unger, MD, President and CEO of NuvOx Pharma, said, "Scientists at NuvOx discovered that application of ultrasound energy to pre-
pSivida U.S., Watertown, Massachusetts, has been assigned a patent developed by two co-inventors for "sustained release drug delivery devices, methods of use, and methods of manufacturing thereof." The co-inventors are Hong Guo, Wayland, Massachusetts, and Paul Ashton, Newton, Massachusetts. Written by Ranjan Behera; edited by Sudarshan Harpal.
Zydus Pharmaceuticals Inc has received final approval from the US health regulator to market Clomipramine Hydrochloride capsules, used to treat obsessive compulsive disorder. Zydus Pharmaceuticals Inc is a wholly-owned subsidiary of Cadila Healthcare Ltd.. Shares of Cadila Healthcare, the listed entity of the group, were up 1.68 per cent at Rs 432.
CAMBRIDGE, Mass.- Agios Pharmaceuticals, Inc., a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for ivosidenib, an investigational oral treatment for patients with relapsed or refractory acute myeloid leukemia
By a News Reporter-Staff News Editor at Drug Week BioVectra Inc., an innovative global contract development and manufacturing organization, announced a long-term supply agreement with Keryx Biopharmaceuticals, Inc., to manufacture Ferric Citrate, the active pharmaceutical ingredient in Auryxia tablets, a medicine approved for the treatment of
Tenders are invited for Buprenorphine transdermal patch 10 mcg/ hr.mfg-modi mundi pharma pvt. Type: Open Major organization: CHITTRANJAN LOCOMOTIVE WORKS Address: Kolkata, West Bengal Country: India Tender notice number: 0920179275 A Notice type: Tender Notice Open date: 2018-01-18. Tender documents: T431083978.html, 431083978. pdf.
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the section titled "Selected Financial Data" and the audited financial statements and notes thereto and management's discussion and analysis of financial condition and results of operations for the fiscal year ended Septembe
Disposable medical supplies; Groups- Concealed latex gloves, Venopunktion and blood collection devices, Central venous catheters, Supplies for regional anesthesia and acid-base determination, Medical needles, Intravenous cannules, Needle arterial, Sternal puncture needles, Catheters and accessories more info: Location: CROATIA BidDate: 12/27/2017..
PHOENIX- INSYS Therapeutics, Inc., announced today that the U.S. Food and Drug Administration has granted Fast Track designation to the company's cannabidiol oral solution for the treatment of Prader-Willi syndrome, a rare and complex genetic disorder characterized by insatiable appetite in children that often leads to obesity and type 2 diabetes.
Findings in Antidiabetic Agents Reported from Louvain Drug Research Institute. According to news originating from Brussels, Belgium, by NewsRx correspondents, research stated, "Nanoparticulate based drug delivery systems have been extensively studied to efficiently encapsulate and deliver peptides orally. Our news journalists obtained a quote from.
Albany, NY 12/29/2017 This report on the Global Ocular Drug Delivery Technology market analyzes the current and future scenario of the global market. Rise in private and public funding for R&D of novel drug delivery technologies, increase in prevalence of macular degeneration& diabetic retinopathy, and favorable regulatory scenario for introd
HERTFORDSHIRE, England and PITTSBURGH, Dec. 29, 2017/ PRNewswire/ Global pharmaceutical leader Mylan N.V. today announced the U.S. launch of Estradiol Vaginal Cream USP, 0.01%, the first generic version of Allergan's Estrace Cream. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application
By a News Reporter-Staff News Editor at Health& Medicine Week A patent by the inventors Beamer, Cynthia L.; Kilcoin, Chris, filed on February 2, 2011, was published online on December 12, 2017, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. One example of an intraosseous device and support device is d
PRINCETON- Agile Therapeutics, Inc.,, a women's healthcare company, today announced that the U.S. Food and Drug Administration issued a complete response letter in response to the New Drug Application resubmission for the Company's investigational non-daily, low dose combination hormonal contraceptive patch, Twirla. The CRL states that the FDA has.
Becton, Dickinson and Co., Franklin Lakes, New Jersey, has been assigned a patent developed by eight co-inventors for a "low dose prefilled drug delivery device and method." The co-inventors are Margaret Taylor, Groton, Massachusetts, James Bates, Sparta, New Jersey, Roman Tunkel, Burlington, Massachusetts, Jay Butterbrodt, North Andover, Massachus
Cingulate Therapeutics, LLC, a clinical stage biopharmaceutical company focused on the development of new and innovative products utilizing its precision timed release drug delivery platform technology, today announced that Cingulate's Chairman and Chief Executive Officer, Shane J Schaffer, will present at the 10th Annual Biotech Showcase? on T
'Shock, the inability to maintain blood flow to vital tissues, can result in organ failure and death,' said Norman Stockbridge, M.D., Ph.D., director of the Division of Cardiovascular and Renal Products in the FDA's Center for Drug Evaluation and Research.' There is a need for treatment options for critically ill hypotensive patients who do not ade
Glenmark Pharmaceuticals has been granted final approval by the United States Food& Drug Administration for Norethindrone Acetateand Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets, 1 mg/20 mcg, the generic version of Minastrin 1 24 Fe Tablets, of Allergan Pharmaceuticals International.
Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food& Drug Administration for Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets, of Allergan Pharmaceuticals International Limited. Its current portfolio consists of 130 products authorized for distribution in the U.S....
Global Needle-free Injection Systems Market was valued at $8.20 billion in 2016, and is estimated to reach $24.9 billion by 2023, growing at a CAGR of 17.4% during the forecast period. Needle free injection technology includes a wide range of drug delivery systems which are used to drive drugs through the skin using any of the forces such as Lore
Albany, NY 12/28/2017 Home infusion therapy services offer an innovative healthcare services at the doorsteps. Infusion therapy administer medication through needle or a catheter. Infusion therapy is generally used when the patient's condition is very severe and cannot be cured with the oral medication.
Horizon Pharma plc today announced the U.S. Food and Drug Administration has approved an expansion to the indication for PROCYSBI delayed-release capsules to include children one year of age and older living with nephropathic cystinosis. PROCYSBI was previously FDA- approved for adults and children as young as two years of age. Data included in the
KENILWORTH, N.J.& NEW YORK- Merck, known as MSD outside the United States and Canada, and Pfizer Inc., today announced that the U.S. Food and Drug Administration has approved STEGLATROTM tablets, an oral sodium-glucose cotransporter 2 inhibitor, and the fixed-dose combination STEGLUJAN tablets. STEGLATRO is indicated as an adjunct to diet and exerc
By a News Reporter-Staff News Editor at Politics& Government Week From Washington, D.C., VerticalNews journalists report that a patent application by the inventor MATOS, JEFFREY A., filed on August 3, 2015, was made available online on December 14, 2017. No assignee for this patent application has been made. News editors obtained the following qu
In 2016, Medtronic Plc. was the first company to receive the U.S. Food& Drug Administration approval for leadless pacemaker, Micra. Biotronik received approval for its leadless ICD system, which is first of its kind, in the U.S. in July 2017. Moreover, in 2016, Medtronic plc was the first company to receive FDA approval for magnetic resonance imagi